You are here

  • Home
  • Archive
  • Volume 86, Issue 11
  • Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the ‘old’ therapies?

Article metrics

Article menu
Download PDFPDF
Editorial commentary
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the ‘old’ therapies?

 

Online download statistics by month:

Online download statistics by month: September 2015 to March 2024

AbstractFullPdf
Sep 20153193739
Oct 20152313542
Nov 2015892232
Dec 201595220
Jan 201657711
Feb 2016811623
Mar 20162464
Apr 201657413
May 201640410
Jun 201632410
Jul 20162511
Aug 20163115
Sep 20163726
Oct 20163412
Nov 20163033
Dec 20163214
Jan 20172831
Feb 20173593
Mar 201735106
Apr 20173210
May 20172410
Jun 20173620
Jul 20174922
Aug 20177820
Sep 20179021
Oct 20179734
Nov 201710520
Dec 20174300
Jan 20186240
Feb 20184921
Mar 20184651
Apr 20186220
May 20187711
Jun 201812020
Jul 20187900
Aug 20186210
Sep 20185800
Oct 20183600
Nov 20185500
Dec 20186020
Jan 20194612
Feb 20193000
Mar 20196211
Apr 20193111
May 20194621
Jun 20193000
Jul 20192731
Aug 20193400
Sep 20191200
Oct 20192800
Nov 20192911
Dec 20193800
Jan 20202600
Feb 20201400
Mar 2020400
Apr 2020710
May 20202100
Jun 2020800
Jul 20201000
Aug 2020600
Sep 20204600
Oct 20201300
Nov 20201920
Dec 20201900
Jan 20212600
Feb 20212110
Mar 20213400
Apr 2021820
May 2021400
Jun 2021220
Oct 20211210
Nov 20212610
Dec 20211400
Jan 20221000
Feb 20222800
Mar 20222200
Apr 20222000
May 20224000
Jun 20223210
Jul 20222710
Aug 20222910
Sep 20222700
Oct 20222800
Nov 20221000
Dec 2022600
Jan 2023810
Feb 20237000
Mar 2023511
Apr 2023400
May 20231200
Jul 2023600
Aug 2023600
Sep 2023400
Oct 2023900
Nov 20231000
Dec 20233521
Jan 20241200
Feb 2024600
Mar 20241400
Total3865228254